NCT00818961 · OUTCOME

Complete Donor Chimerism

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer · Source last updated 2013-12-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

What was measured

Complete donor chimerism (defined as \>/= 95% donor cells in peripheral blood CD3+ and CD33+ was measured.

Analysis population: 36 patients underwent hematopoietic stem cell transplant and therefore were eligible for evaluation of donor chimerism

All patients receive a hematopoietic stem cell transplant using one of two chemotherapy regimens based on disease type

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Hematopoietic Stem Cell Transplantation	36

Source class 1

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Hematopoietic Stem Cell Transplantation	26	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

denoms

description

Complete donor chimerism (defined as \>/= 95% donor cells in peripheral blood CD3+ and CD33+ was measured.

groups

param Type

NUMBER

population Description

36 patients underwent hematopoietic stem cell transplant and therefore were eligible for evaluation of donor chimerism

reporting Status

POSTED

time Frame

2 years

title

Complete Donor Chimerism

type

SECONDARY

unit Of Measure

participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice